Predict • Prevent • Treat Disease
Filter and search through our comprehensive catalog of Next-Generation Sequencing (NGS), Sanger capillary sequencing, Microarray, and Cytogenetic panels.
Compare NGS, Cytogenetic, and Prenatal modalities to select the optimal diagnostic tier for your patient's clinical phenotype.
| Diagnostic Modality | Coverage / Target Scope | Primary Clinical Indication | Specimen Volume | Turnaround Time | Action |
|---|---|---|---|---|---|
| Whole Exome (WES) | ~20,000 Genes (Coding Exons + CNVs) | Unexplained syndromic disorders, ID/GDD | 3-5 mL EDTA Blood | 14-18 Working Days | |
| Clinical Exome (CES) | ~6,000 Clinically Validated OMIM Genes | Monogenic phenotypes, target deep coverage (>120x) | 3-5 mL EDTA Blood | 10-14 Working Days | |
| NIPT Comprehensive | Trisomy 21, 18, 13, SCA & Microdeletions | Aneuploidy screen from 10+ weeks gestation | 10 mL Streck BCT Tube | 5-7 Working Days | |
| Microarray (CMA 750K) | Whole genome CNVs, microdeletions & LOH/AOH | Congenital anomalies, autism spectrum, POC | 3-5 mL Blood / Amniotic | 10-12 Working Days | |
| Hereditary Cancer Panel | BRCA1/2, PALB2, TP53, Lynch MMR Genes | Familial breast, ovarian, colon cancer risk | 3-5 mL Blood / Saliva | 10-12 Working Days |
Our bioinformaticians and molecular scientists can customize high-depth target capture assays for rare familial phenotypes or clinical research protocols.